Synonyms: BLU 945 | BLU945 | Compound 150 [WO2021133809A1]
Compound class:
Synthetic organic
Comment: BLU-945 is a potent, non-covalent, and orally available EGFR inhibitor (4th generation, wild type-sparing), that was designed to inhibit the EGFR pathway and provide anti-tumour activity in NSCLC with EGFR resistance mutations (EGFR with T790M/C797S triple mutant that confers resistance to the 3rd generation EGFR inhibitor osimertinib). Its structure was revealed during the 'first disclosure' session at the ACS Spring 2022 meeting, and this was matched by the Guide to PHARMACOLOGY team to one of the structures (compound 150) in Blueprint Medicines' patent WO2021133809A1 [1], and this association was confirmed by peer-reviewed publication of BLU-945's discovery in summer 2022 [2]. The chemical structure of BLU-945 matches that of the INN tigozertinib (proposed INN list 130, Feb. 2024).
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine |
International Nonproprietary Names ![]() |
|
INN number | INN |
12960 | tigozertinib |
Synonyms ![]() |
BLU 945 | BLU945 | Compound 150 [WO2021133809A1] |
Database Links ![]() |
|
GtoPdb PubChem SID | 461663503 |
PubChem CID | 156538665 |
Search Google for chemical match using the InChIKey | LIMFPAAAIVQRRD-BCGVJQADSA-N |
Search Google for chemicals with the same backbone | LIMFPAAAIVQRRD |
Search PubMed clinical trials | tigozertinib |
Search PubMed titles | tigozertinib |
Search PubMed titles/abstracts | tigozertinib |
UniChem Compound Search for chemical match using the InChIKey | LIMFPAAAIVQRRD-BCGVJQADSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LIMFPAAAIVQRRD-BCGVJQADSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
BLU-945 (links to external site)
Cat. No. HY-144680 |